Attorneys representing women who have been seriously harmed by Yaz expect that the number of lawsuits against Bayer will escalate dramatically in the coming years, possibly involving thousands of plaintiffs. A 41-year-old writer from Bethesda, Maryland, who is one of the most recent plaintiffs to file a lawsuit against Bayer, recently described her experience taking the drug to the Washington Times.
The plaintiff began taking Yaz after her gynecologist reassured her of the drug’s benefits and safety. After weeks of using Yaz, however, the woman began experiencing severe pain that sent her to the emergency room twice for general treatment and CT scans.
It took 13 hours for doctors to finally discover the problem. According to the Times, “In her left lung, the pulmonologist told her, was the largest blood clot they had ever seen and there were others in her right lung as well.”
The woman spent 6 days in the hospital as she was treated with 2 types of blood thinners to dissolve the clots in her lungs. Doctors expected a good recovery but told her that she might never be completely the same . Two weeks after the treatment, she told the Times that she is “incredibly tired most of the time.”
The plaintiff said that a couple of days after the treatment the severity of her situation suddenly hit her. “Wow, I almost died,” she told the Times. Now she strives to tell others about how Yaz affected her and has put the lives of so many other women in danger.
“It’s not just about women who are my age,” she told the Times, adding that lots of younger women are being seriously injured by the drug.
“There’s no reason for blood clots to be forming except for this pill and it’s a very scary situation,” she said.
Bayer has defended itself and Yaz against the allegations, pointing to the two Bayer-funded studies that showed the drug had a safety profile similar to other, more traditional oral contraceptives.
Another Yaz study, not funded by Bayer, found women who took Yaz to be more at risk for blood clots, heart attacks, and strokes. Those results were echoed by a more recent study published by the British Medical Journal in August.